In the treatment of
patients with
stage II (N0, N1)
HR+/HER2- eBC

stage II

I

I

1

with stage II ER+
eBC will experience
distant recurrence¹

~1

in

3

patients

I

I

stage II

In stage II (N0, N1)
HR+/HER2- eBC

Today’s
treatments
leave this

risk largely  
unaddressed^2,3

Explore this
unmet medical
need at

MindEBCGap.com